Results 11 to 20 of about 50 (40)
The Drug-Eluting Stent Saga [PDF]
Circulation, 2009 Drug-eluting stents (DES) represent a breakthrough technology owing to their potent reduction of restenosis, which is a nuisance in the quality of life of affected patients, a rare cause of myocardial infarction (MI), and the principal shortcoming of stents compared with coronary artery bypass surgery.
Stephan Windecker, Peter Jüni
openaire +2 more sources
Reviews in Cardiovascular Medicine, 2010 Significant evolution in catheter-based technologies for percutaneous coronary intervention has occurred since the introduction of coronary balloon angioplasty by Andreas Grüntzig in 1977. As balloon angioplasty was supplanted by bare metal stents and subsequently drug-eluting stents (DES), randomized comparative clinical trials have demonstrated a ...
openaire +3 more sources
Stent Thrombosis With Drug-Eluting Stents
Journal of the American College of Cardiology, 2013 First-generation drug-eluting stents (DES), which impart the controlled release of sirolimus or paclitaxel from durable polymers to the vessel wall, have been consistently shown to reduce the risk of restenosis and target vessel revascularization compared with bare metal stents (BMS).
T. Palmerini +6 more
openaire +3 more sources
Drug eluting stents in 2005 [PDF]
Heart, 2005 In the last 3–5 years there has been a major shift in the management of symptomatic, obstructive coronary artery disease, with a move from predominantly surgical to increasingly a percutaneous approach. The perceived benefits of percutaneous coronary intervention (PCI) include patient convenience, ease of service expansion, and the fact that more ...
openaire +3 more sources
Stents and Drug-Eluting Stents [PDF]
Otolaryngologic Clinics of North America, 2009 Synechiae and ostial stenosis are common and troublesome complications following endoscopic sinus surgery. Many investigators have advocated the use of stents to minimize the risk of postoperative stenosis while others have found their use to be of no benefit. This article reviews the advantages and disadvantages of various stents used in sinus surgery,
Karen A. Bednarski, Frederick A. Kuhn
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Seminars in Interventional Radiology, 2022
AbstractEndovascular revascularization strategies have advanced tremendously over the years and are now often considered first line for treatment of peripheral arterial disease. Drug-eluting stents (DESs) have been developed as one of the tools to overcome the limitations of elastic recoil and neointimal hyperplasia observed with balloon angioplasty ...
Chetan, Velagapudi, Sreekumar, Madassery
openaire +2 more sources
AbstractEndovascular revascularization strategies have advanced tremendously over the years and are now often considered first line for treatment of peripheral arterial disease. Drug-eluting stents (DESs) have been developed as one of the tools to overcome the limitations of elastic recoil and neointimal hyperplasia observed with balloon angioplasty ...
Chetan, Velagapudi, Sreekumar, Madassery
openaire +2 more sources
Annual Review of Medicine, 2004
Advances in catheter and stent design have made stent implantation the standard coronary angioplasty procedure. Unfortunately, in-stent restenosis continues to plague this procedure, with the optimum binary restenosis rates reaching ∼10% to 20%. In the past few years, it has become clear that in-stent restenosis is largely due to the migration and ...
Andrew R. Marks, T Cooper Woods
openaire +6 more sources
Advances in catheter and stent design have made stent implantation the standard coronary angioplasty procedure. Unfortunately, in-stent restenosis continues to plague this procedure, with the optimum binary restenosis rates reaching ∼10% to 20%. In the past few years, it has become clear that in-stent restenosis is largely due to the migration and ...
Andrew R. Marks, T Cooper Woods
openaire +6 more sources
, 2012 Imad Sheiban has been Associated Professor of Cardiology at the University of Turin, Italy since 2003. Since 1989, he has performed approximately 10,000 procedures of interventional cardiology. He is actively involved in different research programs participating to several international multicenter trials.
Imad Sheiban, Fabrizio D'Ascenzo
openaire +2 more sources
Drug-eluting stents: a reappraisal [PDF]
Heart, 2010 The introduction of drug-eluting stents (DES) in 2002 revolutionised the field of percutaneous coronary intervention (PCI), by significantly reducing rates of restenosis when compared to bare-metal stents (BMS).1 Following this there was a rapid and unprecedented uptake in their use, such that within a matter of years they were used in approximately 80–
Scot Garg, Patrick W. Serruys
openaire +2 more sources
An Update on Drug-Eluting Stents
Current Treatment Options in Cardiovascular Medicine, 2012Coronary artery disease remains one of the major causes of morbidity and mortality worldwide. Percutaneous coronary intervention has been shown to be an effective treatment for angina pectoris, although it does not provide any prognostic benefit in stable patients.
Scot Garg, Patrick W. Serruys
openaire +4 more sources